Suppr超能文献

产前硫酸镁预防脑瘫:质量改进计划影响的经济评估。

Antenatal magnesium sulphate for preventing cerebral palsy: An economic evaluation of the impact of a quality improvement program.

机构信息

SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

Adelaide Medical School and the Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.

出版信息

Aust N Z J Obstet Gynaecol. 2022 Feb;62(1):168-171. doi: 10.1111/ajo.13459. Epub 2021 Nov 29.

Abstract

Previous work demonstrated that implementing a quality improvement (QI) program improves the uptake of guideline-recommended antenatal magnesium sulphate, a critical intervention known to reduce cerebral palsy risk. Here we estimate potential cost savings attributable to the improved uptake. By expanding coverage from 63 to 83% of eligible women, we estimated that five children potentially would not have received a diagnosis of cerebral palsy, a potential cost saving of $AU4.8 million in lifetime healthcare costs. Our findings strengthen the case for embedding QI approaches in perinatal care to reduce the incidence of cerebral palsy.

摘要

先前的工作表明,实施质量改进(QI)计划可提高指南推荐的产前硫酸镁的采用率,而硫酸镁是一种已知可降低脑瘫风险的关键干预措施。在这里,我们估计了改善采用率所带来的潜在成本节约。通过将覆盖范围从 63%扩大到 83%,我们估计有五个孩子可能不会被诊断为脑瘫,潜在的终生医疗费用节省 480 万澳元。我们的研究结果进一步证明,在围产期护理中嵌入 QI 方法可以降低脑瘫的发生率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验